What happened
Daewoong disclosed a subsidiary's supply contract with Acino Pharma AG, worth US$59.9M, about 5.89% of the subsidiary's recent annual revenue, running through Jun 2036.
For context, this single contract equals about 5.89% of the subsidiary's most recent annual revenue.
| Counterparty | Acino Pharma AG |
|---|---|
| Contract value | US$59.9M |
| vs. subsidiary revenue | 5.89% |
| Through | Jun 2036 (from Jun 2026) |
| Filed | 2026-06-26, Supply contract signed (subsidiary) |
| Source | DART rcept 20260626800612 → open original filing |
Source: DART. Information only, not investment advice.